Related Experiment Video
Updated: May 10, 2026
08:54
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
Published on: July 20, 2014
Management controversies in Barrett's oesophagus
1Department of Upper GI Surgery, Leadon House, Gloucestershire Royal Hospital, Great Western Road, Gloucester, Gloucestershire, GL1 3NN, UK, mxa891@hotmail.com.
Journal of Gastroenterology
|June 6, 2013
Summary
Early endoscopic therapy is recommended for high-grade dysplasia in Barrett's oesophagus, often preferred over surgery. Treatment for low-grade dysplasia is not currently advised due to over-reporting concerns.
Area of Science:
- Gastroenterology
- Oncology
- Surgical Oncology
Background:
- Barrett's oesophagus management has advanced with endoscopic techniques.
- Controversies persist regarding intervention timing and therapy choice (endoscopic vs. surgical).
Purpose of the Study:
- To review current evidence on managing Barrett's oesophagus and associated neoplasia.
- To address clinical controversies in Barrett's oesophagus treatment.
Main Methods:
- Systematic review following PRISMA guidelines.
- Searched Medline, Embase, and Cochrane databases.
- Used keywords: Barrett's oesophagus, dysplasia, intramucosal carcinoma, endotherapy, endoscopic resection, ablation, oesophagectomy.
Main Results:
- Strong evidence supports early endoscopic therapy for high-grade dysplasia (HGD).
- Endoscopic therapy is now favored over oesophagectomy for most HGD cases.
- Focal intramucosal (T1a) carcinomas respond well to endoscopic or surgical therapy; T1b requires surgery.
- Low-grade dysplasia treatment is not recommended due to over-reporting.
Conclusions:
- Endoscopic therapy is the preferred approach for HGD in Barrett's oesophagus.
- Surgical intervention is recommended for submucosal invasive (T1b) carcinomas.
- The role of surveillance in non-dysplastic Barrett's remains debated.
Related Concept Videos
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
01:21Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
01:26Esophageal Strictures-II: Clinical Features and Management
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:30Esophageal Strictures-I: Introduction
Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
01:25Gastroesophageal Reflux Disease
Gastroesophageal reflux disease (GERD) is the backward flow of stomach contents (acid, pepsin, or bile) into the esophagus, causing mucosal inflammation known as esophagitis. It results from failure of antireflux mechanisms, mainly the lower esophageal sphincter (LES), influenced by mechanical and physiological factors.Etiology and Risk FactorsGERD develops when LES function is weakened or when intra-abdominal pressure increases. Risk factors include aging, obesity, and sliding hiatal hernia,...